Fact CheckerSign in

NCT06874725Active, not recruitingPhase 4

Latent Tuberculosis in Type 2 Diabetes

Directly Observed Preventive Therapy (DOPT) for Latent Tuberculosis Infection Patients With Poorly Controlled Diabetes Mellitus

Source: ClinicalTrials.gov · Last updated 13 Mar 2025

Brief summary (registry, in English)

The patients with poorly controlled DM underwent LTBI screening by using QuantiFERON (QFT). QFT-positivity predictors were evaluated. The patients with LTBI received tuberculosis preventive therapy, 9 months of daily isoniazid (9H) or 3 months of weekly rifapentine plus isoniazid (3HP), administered by pulmonologists. The completion rates and inflammatory markers were also investigated.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
552 (actual)
First submitted
8 Mar 2025
Start date
18 Apr 2018
Primary completion date
30 Apr 2024
Lead sponsor
Taichung Veterans General Hospital
NCT number
NCT06874725

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 552
  • From 18 Apr 2018 to the primary completion date, 30 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • active TB
  • immunocompromise (use of immunosuppressors
  • current pregnancy

Who the study is looking for

  • aged ≥45 years
  • poorly controlled DM (pDM), defined as HbA1c ≥9% within the preceding year

Age in the registry: 45 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Taichung Veterans General Hospital
Coordinator of this site? Confirm its status
TaichungTaiwanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.